Lantheus Holdings, Inc. (LNTH)

Nasdaq Pharmaceutical Diagnostics SIC: 2835
A
Pipeline Grade

Financial Position (from SEC Filings)

$500.3M
Cash & Equivalents
$125.1M
Quarterly Burn Rate
$6,451M
Market Cap

Estimated from most recent SEC quarterly filing. View SEC filings

Drug Pipeline (1 Assets)

DrugPhaseIndications
FLORBETABEN F-18
NEURACEQ 		APPROVED —

Upcoming Catalysts

No upcoming catalysts detected for this company.

More Analysis

AI Stock Score

SEC EDGAR fundamental analysis with Claude AI & ChatGPT ratings for LNTH.

SEC EDGAR Filings

All SEC filings for Lantheus Holdings, Inc. on EDGAR.

Full Calendar

View all upcoming FDA catalysts across all biotech companies.